BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19901487)

  • 1. Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.
    Aggarwal A; Jain M; Garg A; Jiloha RC
    Indian J Med Sci; 2009 Oct; 63(10):468-9. PubMed ID: 19901487
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbamazepine augmentation of clomipramine in the treatment of refractory obsessive-compulsive disorder.
    Iwata Y; Kotani Y; Hoshino R; Takei N; Iyo M; Mori N
    J Clin Psychiatry; 2000 Jul; 61(7):528-9. PubMed ID: 10937614
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of the selective serotonin reuptake inhibitor citalopram in a possible animal analogue of obsessive-compulsive disorder.
    Stein DJ; Mendelsohn I; Potocnik F; Van Kradenberg J; Wessels C
    Depress Anxiety; 1998; 8(1):39-42. PubMed ID: 9750979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram. A case report.
    Habermeyer B; Fuhr P; Hiss B; Alber C; Müller-Spahn F
    Pharmacopsychiatry; 2006 Sep; 39(5):193-4. PubMed ID: 16944412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate augmentation in a patient with obsessive-compulsive disorder.
    Van Ameringen M; Patterson B
    J Psychiatry Neurosci; 2015 Sep; 40(5):E31-2. PubMed ID: 26290064
    [No Abstract]   [Full Text] [Related]  

  • 6. Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder.
    Corregiari FM; Bernik M; Cordeiro Q; Vallada H
    Clinics (Sao Paulo); 2012; 67(4):335-40. PubMed ID: 22522758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond depression: citalopram for obsessive-compulsive disorder.
    Pato MT
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S19-26. PubMed ID: 10471169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of childhood obsessive-compulsive disorder with citalopram.
    Maud C; Stein DJ
    S Afr Med J; 1996 Jun; 86(6 Suppl):746, 748. PubMed ID: 9180769
    [No Abstract]   [Full Text] [Related]  

  • 9. Obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.
    Habermeyer B; Fuhr P
    Pharmacopsychiatry; 2007 Mar; 40(2):87. PubMed ID: 17447184
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitor-induced spermatorrhea in 2 patients.
    Nakajima S; Uchida H; Suzuki T; Watanabe K; Kashima H
    J Clin Psychiatry; 2009 Aug; 70(8):1192-3. PubMed ID: 19758534
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose escitalopram treatment in patients with obsessive-compulsive disorder: a naturalistic case series.
    Shim GS; Kang DH; Kwon JS
    J Clin Psychopharmacol; 2008 Feb; 28(1):108-10. PubMed ID: 18204356
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.
    Hammerness PG; Vivas FM; Geller DA
    J Pediatr; 2006 Feb; 148(2):158-65. PubMed ID: 16492422
    [No Abstract]   [Full Text] [Related]  

  • 13. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo.
    Stein DJ; Andersen EW; Overo KF
    Braz J Psychiatry; 2007 Dec; 29(4):303-7. PubMed ID: 18200396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical application of therapeutic drug monitoring: a tale of two patients.
    Preskorn SH
    J Psychiatr Pract; 2008 Sep; 14(5):301-6. PubMed ID: 18832961
    [No Abstract]   [Full Text] [Related]  

  • 15. Citalopram for OCD and Tourette's syndrome.
    Wehr AM; Namerow LB
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):740-1. PubMed ID: 11437010
    [No Abstract]   [Full Text] [Related]  

  • 16. Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [
    Lee J; Kim BH; Kim E; Howes OD; Cho KIK; Yoon YB; Kwon JS
    Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29210107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
    Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
    J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
    Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
    Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram in refractory obsessive-compulsive disorder: an open study.
    Marazziti D; Dell'Osso L; Gemignani A; Ciapparelli A; Presta S; Nasso ED; Pfanner C; Cassano GB
    Int Clin Psychopharmacol; 2001 Jul; 16(4):215-9. PubMed ID: 11459335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density.
    Wolmarans de W; Brand L; Stein DJ; Harvey BH
    Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.